Atenção!


O atendimento às questões referentes ao Repositório Institucional será interrompido entre os dias 20 de dezembro de 2025 a 4 de janeiro de 2026.

Pedimos a sua compreensão e aproveitamos para desejar boas festas!

Logo do repositório

Antimicrobial activity and biocompatibility of alpha-silver tungstate nanoparticles

dc.contributor.authorde Annunzio, Sarah Raquel [UNESP]
dc.contributor.authorLima Moraes, Bruna de [UNESP]
dc.contributor.authorAssis, Marcelo
dc.contributor.authorBarbugli, Paula Aboud [UNESP]
dc.contributor.authorHenrique Ferreira Pereira de Oliveira, Vinícius [UNESP]
dc.contributor.authorLongo, Elson
dc.contributor.authorVergani, Carlos Eduardo [UNESP]
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)
dc.contributor.institutionUniversity Jaume I (UJI)
dc.contributor.institutionUniversidade Federal de São Carlos (UFSCar)
dc.date.accessioned2025-04-29T18:43:18Z
dc.date.issued2025-02-28
dc.description.abstractThe growing global threat posed by microorganisms resistant to conventional antimicrobials underscores the urgent need for novel agents to control infections. The aim of this study was to evaluate the antimicrobial activity and biocompatibility of alpha-silver tungstate (α-Ag2WO4) nanoparticles (NPs) synthesized by the ultrasonic method. The NPs were characterized, and their antimicrobial activity was assessed against Candida albicans, Staphylococcus aureus, and Escherichia coli using the broth microdilution method, determining the minimum inhibitory concentration (MIC) and minimum bactericidal/fungicidal concentration (MBC/MFC). Intracellular reactive oxygen species (ROS) production was detected by fluorescence using the CM-H₂DCFDA probe. Cytotoxicity was evaluated using murine L929 fibroblasts by MTT assay. Cell viability of both microorganisms and L929 fibroblasts was further assessed using Confocal Laser Scanning Fluorescence Microscopy (CLSM). For C. albicans, the MIC was 3.90 μg/mL, and the MFC was 7.81 μg/mL. For S. aureus, the MIC and MBC were both 62.50 μg/mL, while E. coli exhibited MIC and MBC values of 0.48 μg/mL. The biocompatibility assay revealed a significant reduction in cell viability at concentrations starting from 15.62 μg/mL. CLSM images corroborated the results from both microbiological and biocompatibility assays. Additionally, ROS production was detected in all three microorganisms upon exposure to the NPs, confirming their antimicrobial mechanism. In conclusion, α-Ag₂WO₄ NPs effectively inactivated C. albicans, S. aureus, and E. coli. However, a higher concentration was required to inhibit S. aureus compared to E. coli and C. albicans. The biocompatibility assay revealed concentration-dependent cytotoxic effects. These findings highlight the potential of α-Ag2WO4 NPs as antimicrobial agents and suggest further research into their efficacy against biofilms, optimization of their biocompatibility, and the application of these nanomaterials in the incorporation and coating of materials used in biomedical and dental devices.en
dc.description.affiliationSão Paulo State University (UNESP) School of Dentistry, SP
dc.description.affiliationSão Paulo State University (UNESP) School of Pharmaceutical Sciences, SP
dc.description.affiliationDepartment of Physical and Analytical Chemistry University Jaume I (UJI)
dc.description.affiliationCDMF Federal University of São Carlos (UFSCar), SP
dc.description.affiliationUnespSão Paulo State University (UNESP) School of Dentistry, SP
dc.description.affiliationUnespSão Paulo State University (UNESP) School of Pharmaceutical Sciences, SP
dc.identifierhttp://dx.doi.org/10.1016/j.heliyon.2025.e42648
dc.identifier.citationHeliyon, v. 11, n. 4, 2025.
dc.identifier.doi10.1016/j.heliyon.2025.e42648
dc.identifier.issn2405-8440
dc.identifier.scopus2-s2.0-85217962642
dc.identifier.urihttps://hdl.handle.net/11449/299738
dc.language.isoeng
dc.relation.ispartofHeliyon
dc.sourceScopus
dc.subjectAntimicrobial activity
dc.subjectBiocompatibility
dc.subjectNanotechnology
dc.subjectSilver tungstate nanoparticles
dc.titleAntimicrobial activity and biocompatibility of alpha-silver tungstate nanoparticlesen
dc.typeArtigopt
dspace.entity.typePublication
relation.isOrgUnitOfPublication95697b0b-8977-4af6-88d5-c29c80b5ee92
relation.isOrgUnitOfPublication.latestForDiscovery95697b0b-8977-4af6-88d5-c29c80b5ee92
unesp.author.orcid0000-0001-5477-2135[1]
unesp.author.orcid0009-0005-3241-9134[2]
unesp.author.orcid0000-0003-0355-5565[3]
unesp.author.orcid0000-0002-4177-9888[5]
unesp.author.orcid0000-0002-7375-4714[7]
unesp.campusUniversidade Estadual Paulista (UNESP), Faculdade de Ciências Farmacêuticas, Araraquarapt

Arquivos